viewSirius Minerals PLC

Sirius Minerals hires Louise Hardy as director as construction phase nears

"Louise Hardy brings a wealth of experience in delivering large-scale construction projects and we are delighted to add her to our board,” said chairman Russell Scrimshaw.

Olympic park in East London, a major construction project on Hardy's CV
Hardy was infrastructure director at CLM, part of the London 2012 consortium

As it prepares to build a world class underground mine Sirius Minerals PLC (LON:SXX) has hired Louise Hardy – a specialist in major construction projects – as a new director of the company.

Hardy has extensive, more than 25 years, experience in civil engineering and currently holds a part time executive role at Skanska, as well as non-executive roles at government backed Ebbsfleet Development Corporation and the Defence Infrastructure Organisation.

She was previously infrastructure director at CLM, which was part of the consortium that delivered the London 2012 Olympics.

In her role at Sirius Minerals Hardy will be non-executive director. At the same time Stephen Pycroft is leaving the board after two years, as he has increasing work commitments (as chairman of construction consultant Mace).

"Louise Hardy brings a wealth of experience in delivering large-scale construction projects and we are delighted to add her to our board,” said Sirius Minerals chairman Russell Scrimshaw.

Pycroft added: “"I'm proud to have been part of an exciting period at Sirius, during which time major steps forward have been achieved in the development of its North Yorkshire polyhalite project.

"Whilst I am disappointed to be leaving the board at this exciting time, I have known Louise Hardy well since Mace's involvement in the delivery of the London Olympics and I am delighted to support her appointment to the Sirius board.”

Pycroft said he will remain a shareholder of Sirius Minerals, and will act as an advisor to the company.

Quick facts: Sirius Minerals PLC

Price: - -

Market: LSE
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Amryt Pharma releases Q-2 financials that show strong revenue growth as...

Amryt Pharma (Nasdaq: AMYT) CEO Dr Joe Wiley joined Steve Darling from Proactive with news the company saw a nice increase in revenue as they released their Q-2 numbers. Dr Wiley talked about some of the numbers and what was driving that revenue. Wiley also told Proactive the company has, for...

2 hours, 16 minutes ago

2 min read